2
12
18
28
12
12
1a
14
e
12
16
a
a
2
2
a
20
32
1a
2a
19
Faculty
61 16
19
1
49
2
2
1a
32
34
1b
1d
18
34
6a
1d
2 29
1d
25
Kelly D Getz, PhD, MPH
88
6a
Assistant Professor of Epidemiology in Biostatistics and Epidemiology
7
75
Department: Biostatistics and Epidemiology
4
1
b
1d
46
Contact information
40
4
3
3
1d
40
423 Guardian Drive
34 909 Blockley Hall
Philadelphia, PA 19104
26
34 909 Blockley Hall
Philadelphia, PA 19104
2f
Office: 215-746-1969
30
99
30
Email:
kgetz@pennmedicine.upenn.edu
12
kgetz@pennmedicine.upenn.edu
18
Publications
23 a
3
2
4
b
1f
23 a
13
Education:
21 7 BS 14 (Biology) c
30 Millersville University, 1997.
21 8 MPH 19 (Epidemiology) c
42 Boston University School of Public Health, 2009.
21 8 PhD 19 (Epidemiology) c
42 Boston University School of Public Health, 2014.
c
3
27
21 7 BS 14 (Biology) c
30 Millersville University, 1997.
21 8 MPH 19 (Epidemiology) c
42 Boston University School of Public Health, 2009.
21 8 PhD 19 (Epidemiology) c
42 Boston University School of Public Health, 2014.
c
Links
b4 Search PubMed for articles
d
5
3
3
92
Permanent linkb4 Search PubMed for articles
d
2 29
21
1e
1d
24
76
e 29
27
Description of Research Expertise
237 My research interests are broadly focused on the treatment and supportive care of children and young adults with cancer, with the goal of understanding and balancing therapeutic benefits and toxicity risks. I have a specific interest in the emerging field of cardio-oncology with a focus on earlier detection of the cardiotoxic side effects of cancer treatments, and mitigating cardiac disease as a barrier to effective cancer therapy. I also have an interest in identifying and reducing disparities in the treatment and outcomes of pediatric cancers.e 29
23
1ab Dain AS, Li Y, Master S, Bailey CL, Vossough A, Ichord RN, Raffini L, Getz K*, Kwiatkowski JL*: Trends in HU utilization and cerebrovascular outcomes before and after publication of the 2014 National Heart, Lung, and Blood Institute sickle cell disease guidelines. Pediatr Hematol Oncol 43(1): 1-8, Feb 2026 Notes: doi: 10.1080/08880018.2025.2579978. Epub ahead of print. 43 *Drs. Getz and Kwiatkowski contributed equally.
1e0 Jung W, Ko K, Smith AM, Huang A, Xia C, Martei YM, Narayan VK, Clark AS, Lefebvre B, McDermott K, Koropeckyj-Cox D, Fasan O, Hutsell A, Daniels A, Englefield V, Leger KJ, Getz KD, Narayan HK, Marshall JD, Powell-Wiley TM, Yancy CW, Ky B: Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer. JAMA Netw Open 9(1): e2552323, Jan 2026 Notes: doi: 10.1001/jamanetworkopen.2025.52323.
1f6 Zheng DJ, Bhatia S, Mirzaei S, Aplenc R, Armstrong GT, Bona K, Brinkman TM, Brouwers P, Edelstein K, Getz K, Huang IC, Kirchhoff AC, Mostoufi-Moab S, Park ER, Snyder C, Yabroff KR, Yasui Y, Krull K, Nathan PC: Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2026 Notes: doi: 10.1093/jnci/djaf383. Epub ahead of print.
287 Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Early cardiotoxicity and survival in pediatric acute myeloid leukemia: The mediating roles of relapse and salvage chemotherapy intensity. Blood 146(Supplement 1): 5169, Nov 2025 Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
26d Boulter AC†, Khuong QL, Zheng DJ, Jung W, Huang YV, Aftandilian C, Bona K, Elgarten CE, Ghosh T, Gramatges MM, Maloney K, Mian A, Miller TP, Mody R, Myers R, Seif AE, Smith C, Stokke J, Vasanna SH, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Li Y, Aplenc A, Getz KD.: Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed acute myeloid leukemia. Blood 146(Supplement 1): 2848, Nov 2025 Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee. 3 14
291 Zheng DJ†, Bhatia S, Mirzaei S, Aplenc R, Armstrong GT, Bona K, Brinkman TM, Brouwers P, Edelstein K, Getz K, Huang I, Kirchoff AC, Mostoufi-Moab S, Park ER, Snyder C, Yabroff KR, Yaui Y, Krull K, Nathan PC: Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: a report from the DFCI ALL16-001 trial. Blood 146(Supplement 1): 710, Nov 2025 Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
2c3 Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric acute myeloid leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation. Blood 146(Supplement 1): 876, Nov 2025 Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
16b Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients with Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10): piaf091, Oct 2025 Notes: doi: 10.1093/jpids/piaf091.
20e Gramatges MM, Sanclemente LN, Hall L, Taylor OA, Nuño MM, Bhatia S, Chow EJ, Getz KD, Hitzler JK, Li AM, McCloskey K, Nathan PC, O'Brien MM, Patel S, Verma A, Yarbrough AR, Richard MA, Rosser TC, Jacola LM, Lupo PJ, Rabin KR: A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children's Oncology Group. BMC Cancer 25(1): 1611, Oct 2025 Notes: doi: 10.1186/s12885-025-14898-z.
2c
7
1d
1f
Selected Publications
14a Bravo WC, Li Y, Miller TP, Getz K, Cao L, Krause E, Ramos M, Lee J, Gramatges MM, Rabin KR, Scheurer M, Aplenc R, Denburg M: Racial, Ethnic, and Neighborhood Disparities in Acute Kidney Injury in Pediatric Acute Leukemia. Cancer Med 15(5): e71937, May 2026.1ab Dain AS, Li Y, Master S, Bailey CL, Vossough A, Ichord RN, Raffini L, Getz K*, Kwiatkowski JL*: Trends in HU utilization and cerebrovascular outcomes before and after publication of the 2014 National Heart, Lung, and Blood Institute sickle cell disease guidelines. Pediatr Hematol Oncol 43(1): 1-8, Feb 2026 Notes: doi: 10.1080/08880018.2025.2579978. Epub ahead of print. 43 *Drs. Getz and Kwiatkowski contributed equally.
1e0 Jung W, Ko K, Smith AM, Huang A, Xia C, Martei YM, Narayan VK, Clark AS, Lefebvre B, McDermott K, Koropeckyj-Cox D, Fasan O, Hutsell A, Daniels A, Englefield V, Leger KJ, Getz KD, Narayan HK, Marshall JD, Powell-Wiley TM, Yancy CW, Ky B: Air Pollution and Cardiac Remodeling and Function in Patients With Breast Cancer. JAMA Netw Open 9(1): e2552323, Jan 2026 Notes: doi: 10.1001/jamanetworkopen.2025.52323.
1f6 Zheng DJ, Bhatia S, Mirzaei S, Aplenc R, Armstrong GT, Bona K, Brinkman TM, Brouwers P, Edelstein K, Getz K, Huang IC, Kirchhoff AC, Mostoufi-Moab S, Park ER, Snyder C, Yabroff KR, Yasui Y, Krull K, Nathan PC: Neurocognitive impairment and financial hardship in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 2026 Notes: doi: 10.1093/jnci/djaf383. Epub ahead of print.
287 Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Early cardiotoxicity and survival in pediatric acute myeloid leukemia: The mediating roles of relapse and salvage chemotherapy intensity. Blood 146(Supplement 1): 5169, Nov 2025 Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
26d Boulter AC†, Khuong QL, Zheng DJ, Jung W, Huang YV, Aftandilian C, Bona K, Elgarten CE, Ghosh T, Gramatges MM, Maloney K, Mian A, Miller TP, Mody R, Myers R, Seif AE, Smith C, Stokke J, Vasanna SH, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Li Y, Aplenc A, Getz KD.: Influence of air quality on clinical acuity at presentation in pediatric patients with newly diagnosed acute myeloid leukemia. Blood 146(Supplement 1): 2848, Nov 2025 Notes: Poster presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee. 3 14
291 Zheng DJ†, Bhatia S, Mirzaei S, Aplenc R, Armstrong GT, Bona K, Brinkman TM, Brouwers P, Edelstein K, Getz K, Huang I, Kirchoff AC, Mostoufi-Moab S, Park ER, Snyder C, Yabroff KR, Yaui Y, Krull K, Nathan PC: Cumulative incidence of household material hardship and income loss as measures of financial toxicity during pediatric acute lymphoblastic leukemia (ALL) treatment: a report from the DFCI ALL16-001 trial. Blood 146(Supplement 1): 710, Nov 2025 Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
2c3 Khuong QL†, Zheng DJ, Elgarten CE, Boulter AC, Aftandilian C, Bona K, Ghosh T, Gramatges MM, Huang YV, Maloney K, Mian A, Miller TP, Vasanna SH, Mody R, Myers R, Seif AE, Smith C, Stokke J, Winick NJ, Wilkes JJ, Wong V, Fisher BT, Ky B, Li Y, Aplenc A, Getz KD: Initiation of ACE inhibitors or beta-blockers during frontline therapy for pediatric acute myeloid leukemia and the impacts on cardiotoxicity incidence and survival outcomes: A target trial emulation. Blood 146(Supplement 1): 876, Nov 2025 Notes: Oral presentation at Annual meeting of the American Society of Hematology, December 2025. †Presenter is a primary mentee.
16b Vasileiadi E, Elgarten CW, Getz KD, Aplenc R, Fisher BT: Fluoroquinolone Susceptibility and Comparative Outcomes of Gram-negative Bloodstream Infection in Pediatric Patients with Hematologic Malignancy. J Pediatric Infect Dis Soc 14(10): piaf091, Oct 2025 Notes: doi: 10.1093/jpids/piaf091.
20e Gramatges MM, Sanclemente LN, Hall L, Taylor OA, Nuño MM, Bhatia S, Chow EJ, Getz KD, Hitzler JK, Li AM, McCloskey K, Nathan PC, O'Brien MM, Patel S, Verma A, Yarbrough AR, Richard MA, Rosser TC, Jacola LM, Lupo PJ, Rabin KR: A multicenter observational cohort study in survivors of Down Syndrome-associated acute leukemia (ALTE22C1): a report from the Children's Oncology Group. BMC Cancer 25(1): 1611, Oct 2025 Notes: doi: 10.1186/s12885-025-14898-z.
2c
4d
22
22
7
10
a
a
2
2
19
18
10
22
10
11
c
5b © The Trustees of the University of Pennsylvania | Site best viewed a in a supported browser. | Site Design: 57 PMACS Web Team. 3 22
10
c
